|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06826 HAOHAI BIOTEC
Nominal 
27.000 +0.400 (+1.504%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 1,397,112 | 7.000% | 1,305,707 | 956,267 | 845,874 | 493,609 |
| Cost of Sales | (413,817) | 9.103% | (379,291) | (289,484) | (216,790) | (113,053) |
| Gross Profit | 983,295 | 6.140% | 926,416 | 666,783 | 629,084 | 380,556 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 473 | -- | (4,594) | (8,615) | (2,932) | (2,969) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 305 | -6.442% | 326 | 1,501 | 119 | 26 | |
| Profit / (Loss) before Taxation | 262,492 | 5.082% | 249,797 | 97,427 | 274,268 | 11,026 | |
| Taxation | (44,834) | 9.059% | (41,110) | (23,337) | (37,332) | 1,088 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 17,625 | -- | (3,452) | (3,060) | (5,913) | 15,413 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 235,283 | 14.641% | 205,235 | 71,030 | 231,023 | 27,527 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (29,236) | -17.501% | (35,438) | (40,723) | (49,314) | (52,637) |
| Depreciation & Amortisation | 98,572 | -3.146% | 101,774 | 96,839 | 64,306 | 62,375 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 101.000 | 17.442% | 86.000 | 29.286 | 93.571 | 10.714 |
| DPS (cts) | 40.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 39.604% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 25.433 | -- | 23.810 | 22.504315 | 22.960439 | 21.269228 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 235,283 |
| %Change | 14.641% |
| EPS / (LPS) | RMB 1.010 |
| NBV Per Share (¥) | RMB 25.433 |